FDA accepts regulatory submission for Lynparza in metastatic breast cancer
Lynparza has the potential to offer a new treatment option for patients with metastatic breast cancer...
List view / Grid view
Lynparza has the potential to offer a new treatment option for patients with metastatic breast cancer...
The FDA has approved Verzenio to treat advanced or metastatic breast cancer that has progressed after taking therapy...